The P2G3 antibody is the latest in a long line of potential SARS-CoV-2 monoclonal antibody treatments to neutralize a broad range of viral variants.
The P2G3 antibody is the latest in a long line of potential SARS-CoV-2 monoclonal antibody treatments to neutralize a broad range of viral variants.